Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.7 USD | -0.79% | +10.71% | -3.68% |
08/05 | Stifel Adjusts Price Target on Denali Therapeutics to $22 From $26, Maintains Hold Rating | MT |
08/05 | Wedbush Adjusts Denali Therapeutics' Price Target to $30 From $31, Keeps Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.68% | 297.48Cr | |
+7.75% | 11TCr | |
+10.54% | 11TCr | |
+0.41% | 2.23TCr | |
-12.12% | 2.22TCr | |
-5.99% | 1.94TCr | |
-37.36% | 1.79TCr | |
-4.77% | 1.72TCr | |
+6.62% | 1.43TCr | |
+36.05% | 1.25TCr |
- Stock Market
- Equities
- DNLI Stock
- News Denali Therapeutics Inc.
- Oppenheimer Adjusts Denali Therapeutics' Price Target to $70 From $85, Maintains Outperform Rating